BCO vs CRL · P/E 25, rev $5.01B vs rev $4.05B
Brinks Company (BCO) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. CRL currently screens at market cap $7.78B.
Not investment advice. Open the BCO and CRL stock pages for the full models.
Not investment advice.